Elixmed Interventional
Sirolimus / Everolimus Eluting✓ Refurbished QA
Cardiovascular Consumables✓ Certified Factory Refurbished
Drug-Eluting Stents (DES) & Bare-Metal Stents
Ultra-Thin Strut Cobalt-Chromium Coronary Stents with Biodegradable Polymer
Elixmed supplies premier cardiovascular interventional consumables approved by international regulatory bodies. Our Drug-Eluting Stents (DES) feature ultra-thin cobalt-chromium or platinum-chromium strut architectures coated with biodegradable polymers releasing Sirolimus or Everolimus. They deliver superior trackability in tortuous coronary vessels, high radial strength, and negligible target lesion revascularization (TLR) rates.
Warranty:Factory Sterile Guaranteed Expiry Compliance
Availability & Lead Time:Same-Day Emergency Dispatch to Hospitals & Cath Labs Across Gujarat & India
Equipment Financing:Direct Commercial
Regulatory Standards:AERB eLORA & NEMA Compliant
Engineering Metrics
Complete Technical Specifications
| Strut Thickness | 60 to 75 microns (Ultra-Thin) |
| Material Platform | L605 Cobalt Chromium (Co-Cr) |
| Antiproliferative Agent | Sirolimus / Everolimus (1.2 - 1.4 µg/mm²) |
| Polymer Matrix | Bioabsorbable PLGA / PLLA polymer |
| Available Diameters | 2.00 mm, 2.25 mm, 2.50 mm, 2.75 mm, 3.00 mm, 3.50 mm, 4.00 mm |
| Available Lengths | 8 mm, 12 mm, 16 mm, 20 mm, 24 mm, 28 mm, 32 mm, 36 mm, 40 mm, 48 mm |
| Nominal / RBP Pressure | Nominal: 9 atm | Rated Burst Pressure: 16-18 atm |
Key Features & Hardware Architecture
- Ultra-thin strut thickness (60 µm to 75 µm) promoting rapid endothelialization
- Cobalt-Chromium / Platinum-Chromium alloy for optimum radiopacity and radial force
- Bioresorbable polymer coating degrading safely into water and carbon dioxide
- Controlled antiproliferative drug release profile (Sirolimus / Everolimus over 30-90 days)
- Excellent crossing profile and deliverability through highly calcified and tortuous lesions
Clinical Applications & Indications
- Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndrome (ACS)
- De Novo Coronary Lesions, Bifurcations & Left Main Stenosis
- Diabetic & Small-Vessel Coronary Artery Disease
- In-Stent Restenosis Management
Elixmed Factory Refurbishment & QA Benchmark
100% sterile EO (Ethylene Oxide) batch packaging and traceability
Class III Medical Device DCGI / CDSCO and CE Mark compliance standards
Hospital Financing & Turnkey Siting Available
Partner NBFC ProgramsLow Down Payment
Preserve working capital with packages covering up to 80-90% of equipment & room siting costs.
Turnkey AERB Siting
Complete lead lining (2.0-2.5mm), copper RF cages, chillers, and eLORA radiation registration.
Comprehensive Warranty
Factory Sterile Guaranteed Expiry Compliance
Alternative Options
View All